Clinical Trial

A Study of ONO-2020 in Patients With Agitation Associated With Alzheimer's Disease Dementia

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
To evaluate the efficacy and safety of ONO-2020 in patients with agitation associated with Alzheimer's Disease dementia in Japan.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2025-01-27; most recent amendment 2026-05-10.
Status change: Not Yet Recruiting → Recruiting 2025-03-24
Trial Details
NCT Number NCT06803823
Lead Sponsor Ono Pharmaceutical Co., Ltd.
Conditions Agitation Associated With Alzheimer's Disease Dementia
Enrollment 90 participants
Start Date 2025-05-01
Primary Completion 2026-12-31 (estimated)
Study Completion 2027-03-31 (estimated)
Updated on ClinicalTrials.gov 2026-05-12